drugset / Trial / NCT06494111

Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)

NCT06494111

Phase 2 Recruiting 295 enrolled M.D. Anderson Cancer Center
RandomizedSingle-groupOpen-labelSupportive care

Summary

To learn if pentoxifylline and vitamin E or pravastatin can reduce radiation-induced lymphedema/fibrosis.

Timeline

Start
2025-02-13
Primary completion
2029-05-01
Completion
2031-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Pentoxifylline Small molecule Oral
Subject Pravastatin Small molecule 40 mg Oral
Subject Vitamin E Other / unclassified Oral

Indications